GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DHG Pharmaceutical JSC (STC:DHG) » Definitions » Other Income (Expense)

DHG Pharmaceutical JSC (STC:DHG) Other Income (Expense) : ₫-22,798 Mil (TTM As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is DHG Pharmaceutical JSC Other Income (Expense)?

DHG Pharmaceutical JSC's other income expense for the DHG Pharmaceutical JSC's pretax income for the three months ended in Dec. 2023 was ₫-16,765 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2023 was ₫-22,798 Mil.


DHG Pharmaceutical JSC Other Income (Expense) Historical Data

The historical data trend for DHG Pharmaceutical JSC's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DHG Pharmaceutical JSC Other Income (Expense) Chart

DHG Pharmaceutical JSC Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,807.27 -4,254.65 -13,822.64 -7,749.71 -13,798.31

DHG Pharmaceutical JSC Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5,778.24 4,753.56 3,358.35 -14,144.76 -16,765.45

DHG Pharmaceutical JSC Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₫-22,798 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DHG Pharmaceutical JSC  (STC:DHG) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.


DHG Pharmaceutical JSC (STC:DHG) Business Description

Traded in Other Exchanges
N/A
Address
288 Bis Nguyen Van Cu, An Hoa Ward, Ninh Kieu District, Can Tho, VNM
DHG Pharmaceutical JSC produces and trades in pharmaceutical products. It provides various pharmaceutical products in the areas of antibiotic, antifungal, and antiparasitic; analgesic and antipyretic; ear-nose-throat, cough, and asthma; ophthalmic and nervous system; muscular and osteoarticular; digestive; hepatic; cardiovascular and diabetic; vitamins and minerals; and dermal and beauty care.

DHG Pharmaceutical JSC (STC:DHG) Headlines